EMPLOYMENT AGREEMENTEmployment Agreement • July 29th, 2025 • ImageneBio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (this “Agreement”) is made between Ikena Oncology, Inc., a Delaware corporation (the “Company”), and Mark Manfredi, Ph.D. (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Restrictive Covenants Agreements and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive and the Company dated December 8, 2017 (the “Prior Agreement”), and (ii) any offer letter, employment agreement or severance agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • July 29th, 2025 • ImageneBio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (this “Agreement”), effective on April 25, 2022 (the “Effective Date”), is made and entered into by and between Ikena Oncology, Inc., a Delaware corporation (the “Company”), and Jotin Marango (the “Executive”)